Picture of argenx SE logo

ARGX argenx SE Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual income statement for argenx SE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
FinalFinalFinalFinal
Revenue
Total Revenue25.378.541.2497411
Cost of Revenue
Gross Profit381
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1222775198461,131
Operating Profit-96.5-199-478-349-720
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-77.7-176-605-400-729
Provision for Income Taxes
Net Income After Taxes-78.6-181-608-408-710
Net Income Before Extraordinary Items
Net Income-78.6-181-608-408-710
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-78.6-181-608-408-710
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-2.35-4.69-13.4-7.99-13
Dividends per Share

Or unlock with your email

Or unlock with your email